A multicenter, phase II study of Bortezomib (PS-341) in patients with unresectable or metastatic gastric and gastroesophageal junction adenocarcinoma

Gastroesophageal Junction Adenocarcinoma ◽

Multicenter Phase

Abstract P032: Berzosertib plus irinotecan in patients with TP53 mutant gastric/gastroesophageal junction adenocarcinoma: A phase II study

10.1158/1535-7163.targ-21-p032 ◽

2021 ◽

Author(s):

Satya Das ◽

G. Dan Ayers ◽

Jennifer Whisenant ◽

Anwaar Saeed ◽

Edward Kim ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

A Multicenter Phase II Study of AMG 337 in Patients with MET-Amplified Gastric/Gastroesophageal Junction/Esophageal Adenocarcinoma and Other MET-Amplified Solid Tumors

Clinical Cancer Research ◽

10.1158/1078-0432.ccr-18-1337 ◽

2018 ◽

Vol 25 (8) ◽

pp. 2414-2423 ◽

Cited By ~ 23

Author(s):

Eric Van Cutsem ◽

Boguslawa Karaszewska ◽

Yoon-Koo Kang ◽

Hyun Cheol Chung ◽

Veena Shankaran ◽

...

Keyword(s):

Solid Tumors ◽

Esophageal Adenocarcinoma ◽

Phase Ii ◽

Phase Ii Study ◽

Multicenter Phase

Efficacy and safety of first-line systemic chemotherapy with epirubicin, cisplatin plus 5-fluorouracil and docetaxel, cisplatin plus 5-fluorouracil regimens in locally advanced inoperable or metastatic gastric or gastroesophageal junction adenocarcinoma: A prospective phase II study from South India

Indian Journal of Cancer ◽

10.4103/ijc.ijc_168_17 ◽

2017 ◽

Vol 54 (1) ◽

pp. 47 ◽

Cited By ~ 1

Author(s):

T Chaudhuri ◽

KG Babu ◽

KC Lakshmaiah ◽

L Dasappa ◽

LA Jacob ◽

...

Keyword(s):

Phase Ii ◽

Systemic Chemotherapy ◽

South India ◽

Phase Ii Study ◽

Locally Advanced ◽

Efficacy And Safety ◽

First Line ◽

Gastroesophageal Junction Adenocarcinoma ◽

Prospective Phase

Phase II study of cetuximab in combination with FOLFIRI in patients with untreated advanced gastric or gastroesophageal junction adenocarcinoma (FOLCETUX study)

Annals of Oncology ◽

10.1093/annonc/mdl459 ◽

2007 ◽

Vol 18 (3) ◽

pp. 510-517 ◽

Cited By ~ 203

Author(s):

C. Pinto ◽

F. Di Fabio ◽

S. Siena ◽

S. Cascinu ◽

F.L. Rojas Llimpe ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

A phase II study of neoadjuvant docetaxel, oxaliplatin, and S-1 (DOS) chemotherapy followed by surgery and adjuvant S-1 chemotherapy in potentially resectable gastric or gastroesophageal junction adenocarcinoma

Cancer Chemotherapy and Pharmacology ◽

10.1007/s00280-013-2257-z ◽

2013 ◽

Vol 72 (4) ◽

pp. 815-823 ◽

Cited By ~ 29

Author(s):

Inkeun Park ◽

Min-Hee Ryu ◽

Yoon Hee Choi ◽

Hyo Jeong Kang ◽

Jeong Hwan Yook ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Phase II study of epirubicin, oxaliplatin and docetaxel combination in metastatic gastric or gastroesophageal junction adenocarcinoma

Journal of Experimental & Clinical Cancer Research ◽

10.1186/1756-9966-28-34 ◽

2009 ◽

Vol 28 (1) ◽

Cited By ~ 16

Author(s):

Luigi Di Lauro ◽

Laura Giacinti ◽

Maria Grazia Arena ◽

Domenico Sergi ◽

Silvia Ileana Fattoruso ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Panitumumab in combination with modified docetaxel/ cisplatin/5-fluorouracil as first-line treatment in gastric and gastroesophageal junction adenocarcinomas: a multicenter phase II study by the Hellenic Oncology Research Group

Annals of Gastroenterology ◽

10.20524/aog.2018.0311 ◽

2018 ◽

Cited By ~ 1

Author(s):

Nikolaos Kentepozidis

Keyword(s):

Phase Ii ◽

Research Group ◽

Phase Ii Study ◽

Line Treatment ◽

First Line ◽

Oncology Research ◽

Multicenter Phase ◽

First Line Treatment

Docetaxel, Oxaliplatin, and 5‐Fluorouracil (DOF) in Metastatic and Unresectable Gastric/Gastroesophageal Junction Adenocarcinoma: A Phase II Study with Long‐Term Follow‐Up

The Oncologist ◽

10.1634/theoncologist.2019-0330 ◽

2019 ◽

Vol 24 (8) ◽

pp. 1039 ◽

Cited By ~ 6

Author(s):

Ari Joseph Rosenberg ◽

Alfred Rademaker ◽

Howard S. Hochster ◽

Theresa Ryan ◽

Thomas Hensing ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Gastroesophageal Junction Adenocarcinoma ◽

Long Term Follow Up

A multicenter phase II study of irinotecan (CPT), cisplatin (CIS), and bevacizumab (BEV) in patients with unresectable or metastatic gastric or gastroesophageal junction (GEJ) adenocarcinoma

Journal of Clinical Oncology ◽

10.1200/jco.2005.23.16_suppl.4025 ◽

2005 ◽

Vol 23 (16_suppl) ◽

pp. 4025-4025 ◽

Cited By ~ 5

Author(s):

M. A. Shah ◽

D. Ilson ◽

R. K. Ramanathan ◽

A. Levner ◽

D. D’Adamo ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽

Multicenter Phase

A Phase II Study of 5-Fluorouracil, Leucovorin, Adriamycin, and Cisplatin (FLAP) for Metastatic Gastric and Gastroesophageal Junction Adenocarcinoma

American Journal of Clinical Oncology ◽

10.1097/00000421-199706000-00006 ◽

1997 ◽

Vol 20 (3) ◽

pp. 242-246 ◽

Cited By ~ 1

Author(s):

David J. Vaughn ◽

Neal J. Meropol ◽

Christopher Holroyde ◽

David Mintzer ◽

Isaac Nuamah ◽

...

Keyword(s):

Phase Ii ◽

Phase Ii Study ◽